Your browser doesn't support javascript.
loading
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Al-Juhaishi, Taha; Wang, Yingjun; Milton, Denái R; Xu-Monette, Zijun Y; Jabbour, Elias; Daher, May; Im, Jin S; Bashir, Qaiser; Iyer, Swaminathan P; Marin, David; Olson, Amanda L; Popat, Uday; Qazilbash, Muzaffar; Rondon, Gabriela; Gulbis, Alison M; Champlin, Richard E; Young, Ken H; Khouri, Issa F.
Afiliación
  • Al-Juhaishi T; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang Y; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Milton DR; Division of Hematopathology, Duke University Medical Center, Durham, NC, USA.
  • Xu-Monette ZY; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Division of Hematopathology, Duke University Medical Center, Durham, NC, USA.
  • Daher M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Im JS; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bashir Q; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Iyer SP; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marin D; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Olson AL; The Departement of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Popat U; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Qazilbash M; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rondon G; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gulbis AM; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Young KH; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khouri IF; Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Bone Marrow Transplant ; 58(9): 1000-1007, 2023 09.
Article en En | MEDLINE | ID: mdl-37198234
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Trasplante de Células Madre Hematopoyéticas / Relevancia Clínica Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Trasplante de Células Madre Hematopoyéticas / Relevancia Clínica Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos